A New Form of Epstein-Barr Virus Latency in vivo

  • E. Miyashita
  • D. A. Thorley-Lawson
Part of the Current Topics in Microbiology and Immunology book series (CT MICROBIOLOGY, volume 194)

Abstract

Epstein-Barr virus is a human herpesvirus that is associated with a number of tumors including Burkitts lymphoma, immunoblastic lymphoma, Hodgkins lymphoma, rare T cell lymphomas and nasopharyngeal carcinoma, suggesting a relatively broad tissue tropism for the virus in vivo [1,2]. Immunosuppression through allograft transplantation or HIV infection is known to promote the development of EBV positive tumors, particularly immunoblastic lymphomas. In vitro the virus has a strong tropism for B cells which it infects and causes to become latently infected, immortalized lymphoblasts. This is the only model system for EBV latency in a normal cell. These latently infected cells express 9 known latent proteins and high levels of cell surface markers, such as CD23, that are characteristically expressed on activated B cells [3,4].

Keywords

Lymphoma Agarose Germinal Stein Lewin 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Kieff E and Liebowitz D (1990) Epstein-Barr virus and its replication. In: Virology, Second Edition. Fields, BN, et al., eds. Raven Press, p. 1889–1920Google Scholar
  2. 2.
    Miller G (1990) Epstein-Barr virus: Biology, pathogenesis and medical aspects. In: Virology, Second edition, Fields BN, et al., eds. Raven Press, p. 1921–1958Google Scholar
  3. 3.
    Thorley-Lawson DA and Mann KP (1985) Early events in Epstein-Barr virus infection provide a model for B-cell activation. J Exp Med 162: 45–59PubMedCrossRefGoogle Scholar
  4. 4.
    Thorley-Lawson DA Nadler LM Bhan AK and Schooley RT (1985) Blast 2 (EBVCS), an early cell surface marker of human B-cell activation, is superinduced by Epstein-Barr virus. J Immunol 134: 3007–3012PubMedGoogle Scholar
  5. 5.
    Lewin N Aman P Masucci M Klein E Klein G Oberg B Strander H Henle W Henle G 1987 Characterization of EBV-carrying B-cell populations in healthy seropositive individuals with regard to density, release of transforming virus and spontaneous outgrowth. Int J Cancer 39: 472–476PubMedCrossRefGoogle Scholar
  6. 6.
    Yao Q Czarnecka H Rickinson A (1991) Spontaneous outgrowth of Epstein-Barr virus-positive B-cell lines from circulating human B cells of different buoyant densities. Int J Cancer 48: 253–257PubMedCrossRefGoogle Scholar
  7. 7.
    Wagner HJ Bein G Bitsch A Kirchner H (1992) Detection and quantitation of latently infected B lymphocytes in Epstein-Barr virus-seropositive, healthy individuals by polymerase chain reaction J Clin Micro 30: 2826–2829Google Scholar
  8. 8.
    Adams A (1979) The state of the virus genome in transformed cells and its relationship to host cell DNA. In: Epstein MA Achong B (ed) The Epstein-Barr virus Springer-Verlag Berlin pp 155–183Google Scholar
  9. 9.
    Hurley EA Agger S McNeil JA Lawrence JB Calendar A Lenoir G Thorley-Lawson DA (1991) When Epstein-Barr virus persistantly infects B-cell lines, it frequently integrates J Virol 65: 1245–1254Google Scholar
  10. 10.
    Anagnostopoulos I Hummel M Finn T Tiemann M Korbjuhn P Dimmler C Gatter K Dallenbach F Parwaresch MR Stein H (1992) Heterogeneous Epstein-Barr virus infection patterns in peripheral T-cell lymphoma of angioimmunoblastic lymphadenopathy type. Blood 80: 1804–1812PubMedGoogle Scholar
  11. 11.
    Tsoukas CD Lambris JD (1988) Expression of CR2/EBV receptors on human thymocytes detected by monoclonal antibodies. Euro. J. Immunol. 18: 1299–1302CrossRefGoogle Scholar
  12. 12.
    Freedman AS Freeman G Horowitz JC Daley J Nadler LM (1987) B7, a B-cell-restricted antigen that identifies preactivated B cells. J lmmunol 139: 3260–3267.Google Scholar
  13. 13.
    MacLennan IC Liu YL Ling NR (1988) B ceil proliferation in follicles, germinal centre formation and the site of neoplastic transformation in Burkitt’s lymphoma. Curr Top Microbiol Immunol 141: 138–148.PubMedGoogle Scholar
  14. 14.
    Kerr BM Lear AL Rowe M Croom-Carter D Young LS Rookes SM Gallimore PH Rickinson AB (1992) Three transcriptionally distinct forms of Epstein-Barr virus latency in somatic cell hybrids: cell phenotype dependence of virus promoter usage. Virol 187: 189–201.CrossRefGoogle Scholar
  15. 15.
    Rickinson AB Yao QY Wallace LE (1985) The Epstein-Barr virus as a model of virus- host interactions. Brit Med Bull 41:75–79.PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1995

Authors and Affiliations

  • E. Miyashita
    • 1
  • D. A. Thorley-Lawson
    • 1
  1. 1.Dept. of PathologyTufts University School of MedicineBostonUSA

Personalised recommendations